Loss of SETD2 is associated with dysregulation of protein translation in clear cell renal cell carcinoma

Loss of SETD2 is associated with dysregulation of protein translation in clear cell renal cell carcinoma

kidneycancer

7 months
31 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Robert Hapke, Katherine E. Beckermann MD/PhD, W. Kimryn Rathmell MD/PhD, and Scott M. Haake MD Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center presents Loss of SETD2 is associated with dysregulation of protein translation in clear cell renal cell carcinoma. Filmed at the 18th International Kidney Cancer Symposium 2019, Miami, FL.
Up Next Autoplay